These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38918301)

  • 1. Diagnostic accuracy of ultrasound-derived fat fraction for the detection and quantification of hepatic steatosis in patients with liver biopsy.
    Nakamura Y; Hirooka M; Koizumi Y; Yano R; Imai Y; Watanabe T; Yoshida O; Tokumoto Y; Abe M; Hiasa Y
    J Med Ultrason (2001); 2024 Jun; ():. PubMed ID: 38918301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing ultrasound-derived fat fraction and MRI-PDFF for quantifying hepatic steatosis: a real-world prospective study.
    Qi R; Lu L; He T; Zhang L; Lin Y; Bao L
    Eur Radiol; 2024 Oct; ():. PubMed ID: 39414658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content.
    De Robertis R; Spoto F; Autelitano D; Guagenti D; Olivieri A; Zanutto P; Incarbone G; D'Onofrio M
    Radiol Med; 2023 Oct; 128(10):1174-1180. PubMed ID: 37568072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison With MRI Proton Density Fat Fraction as Reference Standard.
    Dillman JR; Thapaliya S; Tkach JA; Trout AT
    AJR Am J Roentgenol; 2022 Nov; 219(5):784-791. PubMed ID: 35674351
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparing Three Ultrasound-Based Techniques for Diagnosing and Grading Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Wang P; Song D; Han J; Zhang J; Chen H; Gao R; Shen H; Li J
    Acad Radiol; 2024 Sep; ():. PubMed ID: 39294051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population.
    Kubale R; Schneider G; Lessenich CPN; Buecker A; Wassenberg S; Torres G; Gurung A; Hall T; Labyed Y
    AJR Am J Roentgenol; 2024 Jun; 222(6):e2330775. PubMed ID: 38506537
    [No Abstract]   [Full Text] [Related]  

  • 7. Real-time ultrasound-derived fat fraction in pediatric population: feasibility validation with MR-PDFF.
    Zalcman M; Barth RA; Rubesova E
    Pediatr Radiol; 2023 Nov; 53(12):2466-2475. PubMed ID: 37667050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Method for Ultrasound-Derived Fat Fraction Using an Integrated Phantom.
    Labyed Y; Milkowski A
    J Ultrasound Med; 2020 Dec; 39(12):2427-2438. PubMed ID: 32525261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.
    Tavaglione F; Flagiello V; Terracciani F; Gallo P; Capparelli E; Spiezia C; De Vincentis A; Palermo A; Scriccia S; Galati G; Napoli N; Daniels SJ; Blau JE; Carlsson B; Khazrai YM; Incalzi RA; Picardi A; Vespasiani-Gentilucci U
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3787. PubMed ID: 38461408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis using ultrasound-derived fat fraction: First technical and clinical evaluation.
    Huang YL; Cheng J; Wang Y; Xu XL; Wang SW; Wei L; Dong Y
    Clin Hemorheol Microcirc; 2024; 86(1-2):51-61. PubMed ID: 37638422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease.
    Jeon SK; Lee JM
    Insights Imaging; 2024 Feb; 15(1):46. PubMed ID: 38353856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.
    Imajo K; Toyoda H; Yasuda S; Suzuki Y; Sugimoto K; Kuroda H; Akita T; Tanaka J; Yasui Y; Tamaki N; Kurosaki M; Izumi N; Nakajima A; Kumada T
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2533-2541.e7. PubMed ID: 34768008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of ATT and UDFF in the diagnosis of non-alcoholic fatty liver: An animal experiment.
    Chen H; Shen H; Han J; Wang P; Song D; Shen H; Wei X; Yang B; Li J
    Heliyon; 2024 Apr; 10(7):e27993. PubMed ID: 38560108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
    Paige JS; Bernstein GS; Heba E; Costa EAC; Fereirra M; Wolfson T; Gamst AC; Valasek MA; Lin GY; Han A; Erdman JW; O'Brien WD; Andre MP; Loomba R; Sirlin CB
    AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study.
    Hirooka M; Ogawa S; Koizumi Y; Yoshida Y; Goto T; Yasuda S; Yamahira M; Tamai T; Kuromatsu R; Matsuzaki T; Suehiro T; Kamada Y; Sumida Y; Hiasa Y; Toyoda H; Kumada T
    J Gastroenterol; 2024 Jun; 59(6):504-514. PubMed ID: 38553657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of hepatic steatosis using two different qualitative ultrasound techniques measured based on magnetic resonance imaging-derived proton density fat fraction.
    Ogawa S; Kumada T; Gotoh T; Niwa F; Toyoda H; Tanaka J; Shimizu M
    Hepatol Res; 2024 Jul; 54(7):638-654. PubMed ID: 38294946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.
    Jang JK; Kim SY; Yoo IW; Cho YB; Kang HJ; Lee DH
    Eur Radiol; 2022 Mar; 32(3):2070-2077. PubMed ID: 34549325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy.
    Krishan S; Jain D; Bathina Y; Kale A; Saraf N; Saigal S; Choudhary N; Baijal SS; Soin A
    Clin Radiol; 2016 Jan; 71(1):58-63. PubMed ID: 26555703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard.
    Mu R; Xia YC; Zhu KY; Lu JY; Luo Q; Zhang L; Lin RK; Cai XB; Qu Y; Lu LG
    J Dig Dis; 2023 Dec; 24(12):691-701. PubMed ID: 37994615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.